Prescribing patterns of lithium or lithium+valproate in manic or mixed episodes: A naturalistic study

International Clinical Psychopharmacology

Volumn 28, Issue 6, 2013, Pages 305-311

  Muti, Matteo ^a   Del Grande, Claudia ^a   Musetti, Laura ^a   Marazziti, Donatella ^a   Pergentini, Irene ^a   Corsi, Martina ^a   Turri, Milo ^a   Umberto Corsini, Giovanni ^a   Dell'Osso, Liliana ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bipolar disorder; Combination treatment; Lithium; Mania; Mixed state; Serum lithium levels; Valproate

Indexed keywords

LITHIUM CARBONATE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIXED MANIA AND DEPRESSION; MONOTHERAPY; PRIORITY JOURNAL; REMISSION;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; TREATMENT OUTCOME; VALPROIC ACID; YOUNG ADULT;

EID: 84885296514     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3283642348     Document Type: Article

References (49)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Washington, DC: American Psychiatric Association
2. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J (2006). Decreased risk of suicides and attempts during long-Term lithium treatment: A meta-Analytic review. Bipolar Disord 8 (Pt 2):625-639
3. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J (2007). Patterns of psychotropic drug prescription for US patients with diagnoses of bipolar disorders. Psychiatr Serv 58:85-91
4. Benedetti A, Lattanzi L, Pini S, Musetti L, Dell'Osso L, Cassano GB (2004). Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. J Affect Disord 79:273-277
5. Bowden CL, Mosolov S, Hranov L, Chen E, Habil H, Kongsakon R, et al. (2010). Efficacy of valproate versus lithium in mania or mixed mania: A randomized, open-12 week trial. Int Clin Psychopharmacol 25:60-67
6. Cade JFJ (1949). Lithium salts in the treatment of psychotic excitement. Med J Aust 36:349-352
7. Cipriani A, Pretty H, Hawton K, Geddes JR (2005). Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. Am J Psychiatry 162:1805-1819
8. Coryell W (2005). Rapid cycling bipolar disorder: Clinical characteristics and treatment options. CNS Drugs 19:557-569
9. Del Grande C, Muti M, Musetti L, Pergentini I, Corsi M, Turri M, et al. (2012). Long-Term treatment of bipolar disorder: How should we use lithium salts? Riv Psichiatry 47:515-526
10. First MB, Spitzer RL, Gibbon M, JBW Williams (2002). Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute
11. Fountoulakis KN, Kontis D, Gonda X, Siamouli M, Yatham LN (2012). Treatment of mixed bipolar states. Int J Neuropsychopharmacol 15:1015-1026
12. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM (2004). Long-Term lithium therapy for bipolar disorder: Systematic review and meta-Analysis of randomized controlled trials. Am J Psychiatry 161:217-222
13. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, et al. (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised openlabel trial. Lancet 375:385-395
14. Gershon S, Chengappa KN, Malhi GS (2009). Lithium specificity in bipolar illness: A classic agent for the classic disorder. Bipolar Disord 11 (Suppl 2): S33-S44
15. Goodwin GM. Consensus Group of the British Association for Psychopharmacology (2009). Evidence-based guidelines for treating bipolar disorder: Revised second edition -recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23:346-388
16. Grof P (2010). Sixty years of lithium responders. Neuropsychobiology 62:8-16
17. Grof P, Mü ller-Oerlinghausen B (2009). A critical appraisal of lithium's efficacy and effectiveness: The last 60 years. Bipolar Disord 11 (Suppl 2): S10-S19
18. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. (2009). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2009 on the treatment of acute mania. World J Biol Psychiatry 10:85-116
19. Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, et al. (2009). A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry 70: 113-121
20. Kessing LV, Forman JL, Andersen PK (2010). Does lithium protect against dementia? Bipolar Disord 12:87-94
21. Licht RW (2012). Lithium: Still a major option in the management of bipolar disorder. CNS Neurosci Ther 18:219-226
22. Lin D, Mok H, Yatham LN (2006). Polytherapy in bipolar disorder. CNS Drugs 20:29-42
23. Machado-Vieira R, Manji HK, Zarate CA Jr (2009). The role of lithium in the treatment of bipolar disorder: Convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11 (Suppl 2):S92-S109
24. Malhi GS, Tanious M, Gershon S (2011). The lithiumeter: A measured approach. Bipolar Disord 13:219-226
25. Malhi GS, Tanious M, Das P, Berk M (2012). The science and practice of lithium therapy. Aust N Z J Psychiatry 46:192-211
26. Manji HK, Duman RS (2001). Impairments of neuroplasticity and cellular resilience in severe mood disorders: Implications for the development of novel therapeutics. Psychopharmacol Bull 35:5-49
27. Masi G, Perugi G, Millepiedi S, Mucci M, Pfanner C, Berloffa S, et al. (2010). Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination. Psychiatry Res 177:192-198
28. McIntyre RS, Yoon J (2012). Efficacy of antimanic treatments in mixed states. Bipolar Disord 14 (Suppl 2):S22-S36
29. McKean A, Vella-Brincat J (2012). Is it NICE to monitor lithium routinely? N Z Med J 125:50-54
30. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR (2012). Lithium toxicity profile: A systematic review and meta-Analysis. Lancet 379:721-728
31. Musetti L, Del Grande C, Marazziti D, Dell'Osso L (2013). Treatment of bipolar depression. CNS Spectr 8:1-11, [Epub ahead of print].
32. Muzina DJ (2009). Pharmacological treatment of rapid cycling and mixed states in bipolar disorder: An argument for the use of lithium. Bipolar Disord 11 (Suppl 2): S84-S91
33. National Institute for Health and Clinical Excellence (NICE) (2009). Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care, update 2009. Available at: Http://guidance.nice.org.uk/CG38 [Accessed 18 April 2013].
34. Nierenberg AA, Friedman ES, Bowden CL, Sylvia LG, Thase ME, Ketter T, et al. (2013). Lithium treatment moderate-Dose use study (LiTMUS) for bipolar disorder: A randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry 170:102-110
35. Nolen WA, Weisler RH (2013). The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: A post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (trial 144). Bipolar Disord 15:100-109
36. Paton C, Barnes TR, Shingleton-Smith A, McAllister-Williams RH, Kirkbride J, Jones PB, et al. (2010). Lithium in bipolar and other affective disorders: Prescribing practice in the UK. J Psychopharmacol 24:1739-1746
37. Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, et al. (2010). Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry 71:1176-1186
38. Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK (2010). Novel insights into lithium's mechanism of action: Neurotrophic and neuroprotective effects. Neuropsychobiology 62:50-60
39. Sbrana A, Bizzarri JV, Rucci P, Gonnelli C, Doria MR, Spagnolli S, et al. (2005). The spectrum of substance abuse in mood and anxiety disorders. Compr Psychiatry 46:6-13
40. Severus WE, Kleindienst N, Seemü ller F, Frangou S, Mö ller HJ, Greil W (2008). What is the optimal serum lithium level in the long term treatment of bipolar disorder -A review. Bipolar Disord 10:231-237
41. Severus WE, Kleindienst N, Evoniuk G, Bowden C, Mö ller HJ, Bohus M, et al. (2009). Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study. J Affect Disord 115:466-470
42. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W (1997). Modification of the Clinical Global Impressions (CGI) scale for the use in bipolar illness (BP): The CGI-BP. Psychiatry Res 73:159-171
43. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, et al. (1997). Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54:37-42
44. Tundo A (2013). Episodio maniacale e ipomaniacale. In: Marazziti D, editor. Psicofarmacoterapia clinica, V edizione. Roma: Giovanni Fioriti Editore s.r.l. pp. 62-70
45. Wijeratne C, Draper B (2011). Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity. Aust N Z J Psychiatry 45:1026-1032
46. Wolfsperger M, Greil W, Rö ssler W, Grohmann R (2007). Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord 99:9-17
47. Yatham LN, Kennedy SH, Parikh SV, Shaffer A, Beaulieu S, Alda M, et al. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013. Bipolar Disord 15:1-44
48. Yildiz A, Vieta E, Leucht S, Baldessarini RJ (2011). Efficacy of antimanic treatments: Meta-Analysis of randomized, controlled trials. Neuropsychopharmacology 36:375-389
49. Young AH, Hammond JM (2007). Lithium in mood disorders: Increasing evidence base, declining use? Br J Psychiatry 191:474-476